Key Details
Price
$20.17Last Dividend
$0.17PE Ratio
56.03Annual ROE
-10.01%Beta
1.37Events Calendar
Next earnings date:
Feb 07, 2025Recent quarterly earnings:
Nov 06, 2024Recent annual earnings:
Feb 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
Nov 12, 2024Next split:
N/ARecent split:
Feb 11, 2010Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
ST. HELIER, Jersey--(BUSINESS WIRE)--MAC Copper Limited ARBN 671 963 198 (NYSE:MTAL; ASX:MAC) is happy to share that it has made changes to its mezzanine debt agreement with Sprott Private Resource Lending II (Collector-2), LP. These changes allow MAC the choice to repay the loan early, as stated in the Amendment Deed. According to this agreement, MAC can choose to pay off the mezzanine loan in full starting from 1 January 2025.
MAC's collection of high-end shopping centers is expected to benefit from strong retail demand, which will help increase leasing activity and emphasize the importance of omnichannel retailing.
SANTA MONICA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) has announced that it will offer 20,000,000 shares of common stock at a price of $19.75 each, aiming for around $395.0 million in total proceeds. Additionally, the underwriters have a 30-day option to buy up to 3,000,000 more shares. This offering is larger than the previously planned 18,000,000 shares and is expected to close on November 27, 2024, pending standard closing conditions.
SANTA MONICA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- The Macerich Company (NYSE: MAC) has announced that it is starting a public offering of 18,000,000 shares of its common stock. The Company plans to give the underwriters a 30-day option to buy an extra 2,700,000 shares.
MAC's performance in the third quarter shows that interest expenses have increased compared to last year. On the other hand, the net operating income from the same centers, which includes money from lease terminations, has gone up.
The main figures for Macerich (MAC) provide an overview of the company's performance for the quarter that ended in September 2024. However, it could be useful to compare some important metrics with Wall Street predictions and the results from the same period last year.
Macerich (MAC) reported quarterly funds from operations (FFO) of $0.38 per share, which is lower than the Zacks Consensus Estimate of $0.40 per share. This is a decrease compared to last year's FFO of $0.44 per share.
Dan Swanstrom has been appointed as the Chief Financial Officer of The Macerich Company.
Instead of just focusing on Wall Street's predictions for Macerich's (MAC) earnings, let's explore some important metrics to better understand how the company might perform in the quarter that ended in September 2024. This will give us a clearer picture of its potential.
The pricing announcement from the Center for Medicare Services took effect on October 1, 2024, enabling BioStem to start its marketing efforts with Venture Medical. This news was reported on October 29, 2024, from Pompano Beach, Florida. BioStem Technologies Inc. is involved in this initiative.
FAQ
- What is the primary business of Macerich?
- What is the ticker symbol for Macerich?
- Does Macerich pay dividends?
- What sector is Macerich in?
- What industry is Macerich in?
- What country is Macerich based in?
- When did Macerich go public?
- Is Macerich in the S&P 500?
- Is Macerich in the NASDAQ 100?
- Is Macerich in the Dow Jones?
- When was Macerich's last earnings report?
- When does Macerich report earnings?
- Should I buy Macerich stock now?